New research from LUMC shows that a specialized clinical pathway for SCAD is a safe and effective approach for this rare heart disease. Patients treated within this pathway underwent fewer invasive procedures and received less unnecessary medication, without increased risk. Aftercare is a key part of the clinical pathway and supports patients in returning to daily life after a heart attack and rebuilding confidence in their bodies.
Read more